AZNAstraZeneca

Median target
calls from the last 12 months
Implied return
median target vs. price
Coverage
1 analysts · 1 calls
updated in the last 12 months
Consensus
1/0/0+1 net
Buy / Hold / Sell

Which analysts are behind AZN's consensus?

See every current rating, price target and the analysts' track records for AstraZeneca — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 1 analysts with calls on AZN updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

AZN elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-08-08InsidersSharma ManiSee RemarksInsider purchase20 sh @ $160.57$3K
2025-10-31CongressLisa McClainMI-MI09Salesince trade +1.8%, vs market +10.5%$1K–$15K
2025-10-30CongressLisa McClainMI-MI09Purchasesince trade +1.9%, vs market -10.8%$1K–$15K
2025-10-30CongressLisa McClainMI-MI09Salesince trade +1.9%, vs market +10.8%$1K–$15K
2025-09-23CongressValerie HoyleOR-OR04Salesince trade +10.4%, vs market +5.1%$1K–$15K
2025-07-22CongressLisa McClainMI-MI09Purchasesince trade +19.9%, vs market -2.3%$1K–$15K
2025-06-09CongressLisa McClainMI-MI09Purchasesince trade +15.7%, vs market -12.7%$1K–$15K
2025-04-21CongressBruce WestermanAR-AR04Salesince trade +26.3%, vs market +23.6%$1K–$15K
2025-03-03CongressBruce WestermanAR-AR04Purchasesince trade +11.0%, vs market -21.3%$1K–$15K
2024-10-29CongressValerie HoyleOR-OR04Purchasesince trade +13.9%, vs market -19.3%$1K–$15K

More: congressional trades on AZN · insider activity · executive branch · trending